Joseph A. Kendra

403 total citations
16 papers, 256 citations indexed

About

Joseph A. Kendra is a scholar working on Infectious Diseases, Animal Science and Zoology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Joseph A. Kendra has authored 16 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 6 papers in Animal Science and Zoology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Joseph A. Kendra's work include Viral gastroenteritis research and epidemiology (14 papers), Animal Virus Infections Studies (6 papers) and Viral Infections and Immunology Research (5 papers). Joseph A. Kendra is often cited by papers focused on Viral gastroenteritis research and epidemiology (14 papers), Animal Virus Infections Studies (6 papers) and Viral Infections and Immunology Research (5 papers). Joseph A. Kendra collaborates with scholars based in United States, Thailand and Germany. Joseph A. Kendra's co-authors include Kentaro Tohma, Gabriel I. Parra, Lauren A. Ford-Siltz, Kelsey A. Pilewski, Cara J. Lepore, Jonathan D. Dinman, Cynthia de la Fuente, Jonathan L. Jacobs, Todd M. Bell and Yamei Gao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Joseph A. Kendra

15 papers receiving 251 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph A. Kendra United States 8 218 85 82 57 36 16 256
Virginia Hargest United States 7 258 1.2× 79 0.9× 157 1.9× 103 1.8× 17 0.5× 10 287
Michel C. Koch Switzerland 9 203 0.9× 75 0.9× 127 1.5× 61 1.1× 10 0.3× 15 235
N. Stella Cuervo France 3 218 1.0× 226 2.7× 63 0.8× 31 0.5× 46 1.3× 4 315
Sharad Saurabh India 9 131 0.6× 44 0.5× 66 0.8× 21 0.4× 74 2.1× 18 252
A. Richardson United States 6 109 0.5× 191 2.2× 46 0.6× 18 0.3× 121 3.4× 16 296
Sophie Jégouic France 8 251 1.2× 314 3.7× 62 0.8× 28 0.5× 87 2.4× 11 381
Lucie Dufková Czechia 8 173 0.8× 84 1.0× 111 1.4× 25 0.4× 18 0.5× 11 209
Hanqin Shen China 10 195 0.9× 79 0.9× 234 2.9× 157 2.8× 34 0.9× 29 316
Y. K. Kwon South Korea 8 165 0.8× 123 1.4× 189 2.3× 30 0.5× 33 0.9× 11 328

Countries citing papers authored by Joseph A. Kendra

Since Specialization
Citations

This map shows the geographic impact of Joseph A. Kendra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph A. Kendra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph A. Kendra more than expected).

Fields of papers citing papers by Joseph A. Kendra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph A. Kendra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph A. Kendra. The network helps show where Joseph A. Kendra may publish in the future.

Co-authorship network of co-authors of Joseph A. Kendra

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph A. Kendra. A scholar is included among the top collaborators of Joseph A. Kendra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph A. Kendra. Joseph A. Kendra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Tohma, Kentaro, Sonja Jacobsen, Joseph A. Kendra, et al.. (2025). GII.17 norovirus re-emerged in the 2020s as a result of dynamic and adaptive evolutionary processes. Nature Communications. 16(1). 11596–11596. 1 indexed citations
2.
Parra, Gabriel I., Kentaro Tohma, Lauren A. Ford-Siltz, Kelsey A. Pilewski, & Joseph A. Kendra. (2025). The saga to monitor and control norovirus: the rise of GII.17. Journal of General Virology. 106(6). 5 indexed citations
3.
Tohma, Kentaro, Kelsey A. Pilewski, Lauren A. Ford-Siltz, et al.. (2025). Highly variable antigenic site located at the apex of GII.4 norovirus capsid protein induces cross-reactive blocking antibodies in a variant-specific manner. Journal of Virology. 99(7). e0065225–e0065225. 2 indexed citations
4.
Tohma, Kentaro, Lauren A. Ford-Siltz, Joseph A. Kendra, & Gabriel I. Parra. (2025). Manipulation of immunodominant variable epitopes of norovirus capsid protein elicited cross-blocking antibodies to different GII.4 variants despite the low potency of the polyclonal sera. Journal of Virology. 99(7). e0061125–e0061125. 1 indexed citations
5.
Ayyar, B. Vijayalakshmi, Joseph A. Kendra, Frederick H. Neill, et al.. (2025). Functional diversity in GII.4 norovirus entry: HBGA binding and capsid clustering dynamics. Proceedings of the National Academy of Sciences. 122(40). e2517493122–e2517493122.
6.
Pilewski, Kelsey A., et al.. (2024). Analysis of Archival Sera From Norovirus-Infected Individuals Demonstrates That Cross-Blocking of Emerging Viruses Is Genotype-Specific. The Journal of Infectious Diseases. 230(4). 982–994. 4 indexed citations
7.
Tohma, Kentaro, Lauren A. Ford-Siltz, Kelsey A. Pilewski, et al.. (2024). Antigenic Characterization of Novel Human Norovirus GII.4 Variants San Francisco 2017 and Hong Kong 2019. Emerging infectious diseases. 30(5). 1026–1029. 8 indexed citations
8.
Ford-Siltz, Lauren A., Kentaro Tohma, Joseph A. Kendra, et al.. (2024). Characterization of cross-reactive, non-neutralizing monoclonal antibodies against a pandemic GII.4 norovirus variant. Microbiology Spectrum. 12(12). e0114324–e0114324. 1 indexed citations
9.
Parra, Gabriel I., Kentaro Tohma, Lauren A. Ford-Siltz, et al.. (2023). Minimal Antigenic Evolution after a Decade of Norovirus GII.4 Sydney_2012 Circulation in Humans. Journal of Virology. 97(2). e0171622–e0171622. 24 indexed citations
10.
Ford-Siltz, Lauren A., Kentaro Tohma, Gabriela Alvarado, et al.. (2022). Cross-reactive neutralizing human monoclonal antibodies mapping to variable antigenic sites on the norovirus major capsid protein. Frontiers in Immunology. 13. 1040836–1040836. 11 indexed citations
11.
Tohma, Kentaro, Lauren A. Ford-Siltz, Joseph A. Kendra, & Gabriel I. Parra. (2022). Dynamic immunodominance hierarchy of neutralizing antibody responses to evolving GII.4 noroviruses. Cell Reports. 39(2). 110689–110689. 28 indexed citations
12.
Kendra, Joseph A., Kentaro Tohma, & Gabriel I. Parra. (2022). Global and regional circulation trends of norovirus genotypes and recombinants, 1995–2019: A comprehensive review of sequences from public databases. Reviews in Medical Virology. 32(5). e2354–e2354. 66 indexed citations
13.
Kendra, Joseph A., Kentaro Tohma, Lauren A. Ford-Siltz, Cara J. Lepore, & Gabriel I. Parra. (2021). Antigenic cartography reveals complexities of genetic determinants that lead to antigenic differences among pandemic GII.4 noroviruses. Proceedings of the National Academy of Sciences. 118(11). 39 indexed citations
14.
Kendra, Joseph A., et al.. (2018). Functional and structural characterization of the chikungunya virus translational recoding signals. Journal of Biological Chemistry. 293(45). 17536–17545. 22 indexed citations
15.
Kendra, Joseph A., Cynthia de la Fuente, Todd M. Bell, et al.. (2016). Ablation of Programmed −1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity. Journal of Virology. 91(3). 37 indexed citations
16.
Glasner, Dustin R., et al.. (2012). Optimization of viral profiling approaches reveals strong links between viral and bacterial communities in a eutrophic freshwater lake. Aquatic Microbial Ecology. 67(1). 59–76. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026